Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.

Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the record content. This indicates a permissions issue rather than an update to the study information.SummaryDifference17%

- Check15 days agoChange DetectedThe page now displays revision v3.7.0, replacing the previous v3.6.6, indicating an update to the page template or system version rather than changes to the study data.SummaryDifference0.1%

- Check29 days agoChange DetectedThe revision tag on the page updated from v3.6.5 to v3.6.6, indicating a minor maintenance update to the page.SummaryDifference0.0%

- Check36 days agoChange DetectedNo changes detected on the page. The content appears unchanged.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, signaling a new revision of the page metadata. This change does not alter the study information or layout.SummaryDifference0.0%

- Check65 days agoChange DetectedSponsor information updated to Gossamer Bio USA, Inc., replacing GB002, Inc. and related subsidiary wording. The revision now shows v3.6.4 with dates in July 2026.SummaryDifference0.4%

Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.